Abstract:Keywords: bioanalysis GCLP GLP Good Clinical Laboratory Practice Good Laboratory Practice quality assurance quality management References 1. Food and Drug Administration Searle Investigation Task Force. Report of preclinical (animal) studies of G.D. Searle Company Skokie: Illinois ( 1976 ). Google Scholar 2. De Brabandere L . The forgotten half of change: achieving greater creativity through changes in perception . Diversion Books ( 2016 ). Google Scholar 3. Clinical Trials Transformation Initiative. CTTI recommendations: Quality by Design ( 2015 ). tracs.unc.edu/docs/regulatory/CTTI_Recommendations-Quality_by_Design.pdf Google Scholar 4. American Society for Quality. American Society for Quality What is a quality management system (QMS)? https://asq.org/quality-resources/quality-management-system Google Scholar 5. American Society for Quality. Quality Assurance & Quality Control, Quality glossary definition: Quality Assurance/Quality Control (QA/QC) . https://asq.org/quality-resources/quality-assurance-vs-control Google Scholar 6. Senge P . The fifth discipline: the art and practice of the learning organization . New York: Doubleday, revised & updated edition ( 2006 ). Google Scholar 7. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised guideline: integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2) . Fed. Reg. 82(143), 30829–30872 ( 2017 ). Google Scholar 8. Kaza M, Rudzki P J . Visualizing bioanalytical methods – a near or distant future? Bioanalysis 12(7) ( 2020 ). Google Scholar 9. Fuglsang A . Detection of data manipulation in bioequivalence trials . European J. Pharmaceut. Sci. 156, 105595 ( 2021 ).CAS Google Scholar 10. US Food and Drug Administration, Department of Health and Human Services. Letter to Krathish Bopanna ( 2016 ). https://www.fda.gov/media/97424/download Google Scholar

The Complexity of Compliance in Sample Management: A Review of Key Issues Impacting Small-Molecule and Biological Sample Management in Early Drug Discovery

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

The state of the art in secondary pharmacology and its impact on the safety of new medicines

Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals

The challenges for implementing Good Clinical Practices in the bioanalytical laboratory: a discussion paper from the European Bioanalysis Forum

Case Studies on the use of Microsampling for Nonclinical Studies in Pharmaceutical Drug Discovery and Development

Advancing automation in Compound Management: a novel industrial process underpinning drug discovery

Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics

The Pistoia Alliance Controlled Substance Compliance Service Project: from start to finish

Voluntary Exploratory Data Submissions to the Us Fda and the Ema: Experience and Impact

Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.

Strategies for Accelerated Drug Development: An Industry Perspective Based on an IQ Consortium Survey of CMC Considerations

Entering the era of computationally driven drug development

Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development

The Synergy of Molecular Docking and Bioinformatics: An in Depth Review in Drug Discovery

Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls

Occurrence of ‘Natural Selection’ in Successful Small Molecule Drug Discovery

Bioanalytical Quality Assurance: a Tesla with a trafficator?

Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action